Clinical Trials in Baltimore

Showing 7001-7020 of 17,842 trials

Treatment Goals in Psoriatic Arthritis

NCT03620188

The PaGoPsA study objective is to ascertain if guideline-based psoriatic arthritis clinical care achieves individual patient goals as articulated by patients, and to identify predictors of achieving individual patient goals from psoriatic arthritis treatment.

Psoriatic Arthritis

Johns Hopkins University250 participantsStarted Dec 2018

Baltimore, Maryland, United States

COMPLETEDPhase 3< 1 mile

Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.

NCT04740827

This study will assess the safety, tolerability, and efficacy of Atogepant 60 mg compared with placebo in participants with episodic migraine and who have previously failed 2 to 4 classes of oral prophylactic treatments.

Episodic Migraine

Allergan315 participantsStarted Mar 2021

Colton, California, United States • Encino, California, United States • Los Alamitos, California, United States +111 more locations

Treatment Goals in Psoriatic Arthritis

Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.

Find Trials by Condition in Baltimore

Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome

INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation

Subchondroplasty® Knee RCT

SNS and PrEP Initiation and Adherence in Black SMM

Clinical Use Cases Assessment of the Gabi System in Young Children With Underlying Medical Conditions (BRIDGE Study)

A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

Understanding the Effects of Quantitatively-Prescribing Passive-Dynamic Ankle-Foot Orthosis Bending Stiffness for Individuals Post-Stroke

MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram

Human Epilepsy Project 2: Resistant Focal Seizures Study

A Dose-escalation Study to Evaluate the Safety and Clinical Activity of PBCAR269A, With or Without Nirogacestat, in Study Participants With Relapsed/Refractory Multiple Myeloma

Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)

Study of a Novel Laser for Skin Rejuvenation

Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients